Inspiration, Ispen Partnership Ends with Chapter 11 Filing
By Catherine Shaffer
Staff Writer
Staff Writer
Wednesday, October 31, 2012
A Chapter 11 bankruptcy filing by Inspiration Biopharmaceuticals Inc., of Cambridge, Mass., could result in a loss of up to €120 million (US$155 million) for its partner Ipsen SA, according to a statement by the Paris-based pharma company Wednesday.
To continue reading subscribe now to Latest News
Learn More about Latest News
Already a subscriber? Sign In or Buy now to activate your subscription
Note: our contact information has changed
Customer Care: http://support.clarivate.com
© 2018 Clarivate Analytics.
Reproduction, reposting content is strictly prohibited.
Reproduction, reposting content is strictly prohibited.